Let’s start up with the current stock price of Cogent Biosciences Inc. (COGT), which is $11.99 to be very precise. The Stock rose vividly during the last session to $12.22 after opening rate of $10.79 while the lowest price it went was recorded $10.735 before closing at $10.65.Recently in News on June 16, 2022, Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Pre-funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares. Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its upsized underwritten public offering of 17,899,698 shares of its common stock, and to certain investors in lieu thereof, pre-funded warrants to purchase 3,030,302 shares of its common stock at an exercise price of $0.01 per share. The shares of common stock sold include 2,730,000 shares pursuant to the option to purchase additional shares granted by Cogent to the underwriters, which option was exercised in full. The public offering price of each share of common stock was $8.25 and the public offering price of each pre-funded warrant was $8.24. The aggregate gross proceeds to Cogent from this offering were approximately $172.6 million, before deducting underwriting discounts and commissions and other estimated offering expenses. You can read further details here
Cogent Biosciences Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $12.22 on 08/04/22, with the lowest value was $3.79 for the same time period, recorded on 05/13/22.
Cogent Biosciences Inc. (COGT) full year performance was 81.39%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cogent Biosciences Inc. shares are logging -0.75% during the 52-week period from high price, and 216.36% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.79 and $12.08.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1510606 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Cogent Biosciences Inc. (COGT) recorded performance in the market was 39.74%, having the revenues showcasing 74.02% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.06B, as it employees total of 77 workers.
Market experts do have their say about Cogent Biosciences Inc. (COGT)
During the last month, 0 analysts gave the Cogent Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.82, with a change in the price was noted +6.18. In a similar fashion, Cogent Biosciences Inc. posted a movement of +106.37% for the period of last 100 days, recording 2,001,642 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for COGT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Cogent Biosciences Inc. (COGT)
Raw Stochastic average of Cogent Biosciences Inc. in the period of last 50 days is set at 97.16%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 89.20%. In the last 20 days, the company’s Stochastic %K was 45.98% and its Stochastic %D was recorded 40.25%.
Bearing in mind the latest performance of Cogent Biosciences Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 39.74%. Additionally, trading for the stock in the period of the last six months notably improved by 71.04%, alongside a boost of 81.39% for the period of the last 12 months. The shares increased approximately by 6.29% in the 7-day charts and went down by 10.00% in the period of the last 30 days. Common stock shares were driven by 74.02% during last recorded quarter.